a month ago
SMMT
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 16%
#738 out of 4861 analysts
Average Return
+2.76%
Win Rate
39%90 out of 231
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-05 - 2024-04-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-18 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-24 - 2024-02-26 | Strong Buy |
Summit Therapeutics IncSMMT | +293.31% | $5.31 | $20.89 | 2024-05-07 - 2024-09-27 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
a month ago
LENZ
2 months ago
RIGL
4 months ago
MRUS
5 months ago
APLT
5 months ago
SNDX
7 months ago
SMMT
7 months ago
APLT
7 months ago
AVBP
7 months ago
SMMT
8 months ago
APLT
8 months ago
SNDX
8 months ago
ONC
9 months ago
ARDX
10 months ago
MRUS
a year ago
RCUS
a year ago
SMMT
a year ago
ARDX
a year ago
IDYA
a year ago
MGNX
a year ago
KRYS
a year ago
APLT
a year ago
ARCT
a year ago
ARDX
a year ago
MGNX
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | 5 | Strong Buy | $35.00 | +42.22% | Upgrades | a month ago |
Lenz Therapeutics IncLENZ | 2 | Strong Buy | $47.00 | +97.31% | Maintains | a month ago |
Zymeworks IncZYME | 12 | Strong Buy | $19.00 | +64.79% | Maintains | a month ago |
Arvinas IncARVN | 8 | Hold | $19.00 | +120.93% | Maintains | a month ago |
Rigel Pharmaceuticals IncRIGL | 11 | Strong Buy | $55.00 | +226.41% | Maintains | 2 months ago |
Syndax Pharmaceuticals IncSNDX | 8 | Strong Buy | $42.00 | +263.95% | Maintains | 2 months ago |
Krystal Biotech IncKRYS | 4 | Hold | $215.00 | +27.54% | Maintains | 2 months ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $25.00 | +447.05% | Initiates Coverage On | 2 months ago |
Crispr Therapeutics AgCRSP | 18 | Strong Buy | $82.00 | +117.10% | Maintains | 2 months ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $33.00 | +481.50% | Initiates Coverage On | 3 months ago |
Merus NvMRUS | 14 | Strong Buy | $97.00 | +125.29% | Maintains | 4 months ago |
Applied Therapeutics IncAPLT | 8 | Strong Buy | $8.00 | +2,302.40% | Maintains | 5 months ago |
Caribou Biosciences IncCRBU | 5 | Strong Buy | $6.00 | +716.33% | Maintains | 5 months ago |
Apellis Pharmaceuticals IncAPLS | 12 | Strong Buy | $51.00 | +180.22% | Maintains | 5 months ago |
Ardelyx IncARDX | 10 | Strong Buy | $10.00 | +107.68% | Maintains | 6 months ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $27.00 | +202.69% | Initiates Coverage On | 6 months ago |
Shattuck Labs IncSTTK | 4 | Hold | $2.00 | +158.73% | Downgrades | 7 months ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $36.00 | +98.46% | Maintains | 7 months ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $58.00 | +239.58% | Maintains | 8 months ago |
Biomea Fusion IncBMEA | 8 | Strong Buy | $22.00 | +1,201.78% | Maintains | 8 months ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | +1,011.11% | Maintains | 8 months ago |
Beigene LtdONC | 4 | Strong Buy | $288.00 | +24.69% | Maintains | 8 months ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | +315.22% | Maintains | 10 months ago |
Arcus Biosciences IncRCUS | 6 | Strong Buy | $38.00 | +382.23% | Maintains | a year ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | -2.50% | Downgrades | a year ago |
Oric Pharmaceuticals IncORIC | 5 | Strong Buy | $14.00 | +193.50% | Maintains | a year ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | N/A | Maintains | a year ago |
Zai Lab LtdZLAB | 7 | Strong Buy | $66.00 | N/A | Maintains | a year ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | N/A | Downgrades | a year ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Strong Buy | $48.00 | N/A | Maintains | a year ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | N/A | Downgrades | a year ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 4 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | 2 years ago |
Lexicon Pharmaceuticals IncLXRX | 5 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Unity Biotechnology IncUBX | 6 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Opthea LtdOPT | 2 | Strong Buy | $44.00 | N/A | Maintains | 3 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 4 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 6 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 6 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.